Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 28.16 USD -1.09% Market Closed
Market Cap: 1.7B USD

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 52.5 USD with a low forecast of 44.44 USD and a high forecast of 65.1 USD.

Lowest
Price Target
44.44 USD
58% Upside
Average
Price Target
52.5 USD
86% Upside
Highest
Price Target
65.1 USD
131% Upside
Twist Bioscience Corp Competitors:
Price Targets
OPK
OPKO Health Inc
221% Upside
CUV
Clinuvel Pharmaceuticals Ltd
148% Upside
APGE
Apogee Therapeutics Inc
136% Upside
688278
Xiamen Amoytop Biotech Co Ltd
41% Upside
NYKD
Nykode Therapeutics ASA
107% Upside
BBIO
BridgeBio Pharma Inc
83% Upside
CYTK
Cytokinetics Inc
158% Upside
300896
Imeik Technology Development Co Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

62%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
52.5 USD

According to Wall Street analysts, the average 1-year price target for TWST is 52.5 USD with a low forecast of 44.44 USD and a high forecast of 65.1 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

Back to Top